Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue for the Prevention of Hypotension During Renal Replacement Therapy
NCT05092165Phase 2Completed
- Sponsor
- Federal University of São Paulo
- Start
- Oct 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of methylene blue in intradialytic hypotension (IDH) (2 arms), sponsored by Federal University of São Paulo. Primary endpoint: Composite Endpoint at 6 hours. Started Oct 2021; status: completed.
02
Drugs
methylene blue
03
Conditions
intradialytic hypotension (IDH)
Beyond the preview
Go deeper on NCT05092165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05092165.